Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

4 clinical studies listed.

Filters:

Gynaecological Cancer

Tundra lists 4 Gynaecological Cancer clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

RECRUITING

NCT06863090

In Vivo Dosimetry for Brachytherapy Study

The main study aim is the investigate the clinical use of in vivo dosimeters (small measurement devices) for brachytherapy (internal radiotherapy).

Gender: All

Ages: 18 Years - Any

Updated: 2025-03-11

1 state

Prostate Cancer
Gynaecological Cancer
ENROLLING BY INVITATION

NCT06713122

Effects of Symptom Management Education With Mobile Application in Gynecological Cancer Patients Receiving Chemotherapy

Gynaecological cancers, which have an important place among the cancers seen both in the world and in our country. Chemotherapy, which is one of the most commonly used and basic methods in cancer treatment, causes many physical and psychological side effects while treating the disease. It is very important to identify the symptoms experienced, evaluate, control and provide professional health guidance. The spread of digitalisation has turned mobile learning into a kind of need or necessity rather than a preference. Increases the control of individuals over themselves and provides self-discipline. The aim of this study was to evaluate the effect of symptom management training given with an artificial intelligence supported mobile application on supportive care needs, symptom severity and psychological well-being of gynaecological cancer patients receiving chemotherapy. The study was planned as a randomised controlled trial. The population of the study will consist of patients who applied to Etlik City Hospital-Oncology Hospital-Day Outpatient Unit for the first time to receive chemotherapy treatment for gynaecological cancer and completed the first course. The study will be conducted with a total of 70 patients, including 35 patients from the intervention group and 35 patients from the control group. Research Hypotheses: Gynaecological cancer patients receiving chemotherapyBetween the intervention group receiving symptom management training with a mobile application and the control group receiving standard care; 1. H1: There is a difference in terms of the severity of symptoms experienced. 2. H2: There is a difference in terms of supportive care needs. 3. H3: There is a difference in terms of psychological well-being levels. Data Collection Tools Descriptive Information Form, Edmonton Symptom Diagnostic Scale, Supportive Care Needs Scale, Psychological Well-Being Scale and Eastern Cooperative Oncology Group (ECOG) Performance Scale will be used as data collection tools. Modules to be included in the Mobile Application: The forms will be administered a total of three times, initially at the end of the 3rd and 5th cycle. Module 1: Introducing Module Module 2: Application Usage Instruction Module Module 3: Recognise the Disease Module Module 4: Common Symptoms and Recommendations During Chemotherapy Treatment Module Module 5: Let's Fight Symptoms Together Module Module 6: Ask Anything - Counselling Module

Gender: FEMALE

Ages: 18 Years - Any

Updated: 2024-12-03

Gynaecological Cancer
Chemotherapy
Nursing Care
RECRUITING

NCT05142150

Palliation in Gynae-oncology: Patients Expectations and Assessment of Care (PEACE)

The overall aim is to assess the feasibility and acceptability of collecting data on the patients and carers perception of care as well as to prospectively monitor end of life care.

Gender: FEMALE

Ages: 18 Years - Any

Updated: 2024-10-01

Gynaecological Cancer
NOT YET RECRUITING

NCT05918770

Side Effects Screening and Early Intervention to Impact in Quality of Life of Gynaecological Cancer Patients

The goal of this randomized study is to assess the impact on self-perceived quality of life (QoL) of systematic screening and early treatment of aftereffects in patients with gynaecological cancers. The main question it aims to answer is if systematic screening with validated questionaries (see in detailed description), diagnosis and early treatment of lower-limb lymphoedema, anxiety-depression, sexual dysfunction and sarcopenia-malnutrition all have a positive impact on the self-perceived QoL by gynaecological cancer patients. Participants will access the screening questionnaires and QoL questionaries on a free online app on their mobile devices. In the experimental group, in case of positive screening, patients will be referred to specialised care to early treatment of the aftereffects. Researchers will compare this group with standard usual care (opportunistic treatment) to see if systematic screening and early treatment lead to a better QoL.

Gender: FEMALE

Ages: 18 Years - Any

Updated: 2023-06-26

Quality of Life
Gynaecological Cancer
Lymphedema, Lower Limb
+1